| ¿µ¹® | acute hepatitis | ÇÑ±Û | ±Þ¼º°£¿° |
|---|---|---|---|
| ¼³¸í | ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ °£¿¡ »ý±â´Â ±Þ¼º¿°Áõ. ±Þ¼º°£¿°À̶õ °£¿°¹ÙÀÌ·¯½º(AÇü-BÇü-ºñAºñBÇü)¿¡ ÀÇÇØ¼ °£¿¡ »ý±â´Â ±Þ¼º¿°ÁõÀ» º´¸íÀ¸·Î À̸£´Â ¸»·Î, ÀÌ´Â ±× °¨¿°¾ç½Ä¿¡ ¼öÇ÷ ÈÄ¿¡ ¹ß»ýÇÏ´Â ¼öÇ÷ÈÄ °£¿°°ú, °¨¿°°æ·Î¸¦ ¾Ë ¼ö ¾ø´Â »ê¹ß¼º°£¿° ¹× Áý´ÜÀ¸·Î ¹ß»ýÇÏ´Â À¯Ç༱°£¿°ÀÇ ¼¼°¡Áö À¯ÇüÀ¸·Î ³ª´ ¼ö ÀÖ´Ù. ¼öÇ÷ÈÄ °£¿°Àº ±× 95%°¡ ºñAºñBÇü°£¿°ÀÌ¸ç ³ª¸ÓÁö°¡ BÇü °£¿°ÀÌ´Ù. »ê¹ß¼º °£¿°Àº AÇü °£¿°°ú BÇü °£¿°ÀÌ °¢°¢ 30%¸¦ ÀÌ·ç°í ³ª¸ÓÁö 40%´Â ºñAºñB°£¿°ÀÌ´Ù. Áý´ÜÀ¸·Î ¹ß»ýÇÏ´Â À¯Ç༺°£¿°Àº °ÅÀǰ¡ AÇü°£¿°ÀÌÁö¸¸ ¶§·Î´Â ¿©±â¿¡ Æ÷ÇÔµÇÁö ¾ÊÀº ÇüÀÇ °£¿°ÀÏ °æ¿ìµµ ÀÖ´Ù. ±Þ¼º°£¿°ÀÇ Áõ¼¼´Â ¸ÕÀú ¸öÀÌ ³ª¸¥ÇØÁö°í ¿Â¸ö¿¡ ±ÇۨÀÌ Ã£¾Æ¿À¸ç Á¶±×¸¶ÇÑ ÀÏ¿¡µµ °ð ÇǷθ¦ ´À³¢°Ô µÈ´Ù. ±×¸®°í ½Ä¿åºÎÁø-¹ß¿-±¸ÅäÁõ-º¹Åë-¼³»ç µî, °¨±â³ª ±Þ¼ºÀ§Àå¿°¿¡ °É·ÈÀ» ¶§¿Í °°Àº Áõ¼¼ µîÀÌ ³ªÅ¸³´Ù. µÚÀ̾î Ȳ´ÞÁõ¼¼¸¦ º¸À̴µ¥, À̶§´Â ÃʱâÀÇ Áõ¼¼°¡ ¾à°£ °¡º¿öÁø °Íó·³ ´À²¸Áö´Â °ÍÀÌ º¸ÅëÀÌ´Ù. ±×·¯³ª Ȳ´ÞÁõ¼¼°¡ ½ÉÇØÁö°í ÃʱâÀÇ Áõ¼¼µéÀÌ ´Ù½Ã ÁøÇàµÇ¸é À̶§´Â Àü°Ý¼º°£¿°ÀÌ µÉ À§ÇèÀÌ ÀÖ´Ù. °£¿° Áõ¼¼°¡ ½ÉÇÏÁö ¾Ê¾ÒÀ» °æ¿ì´Â Ȳ´ÞÀÌ ´«¿¡ ¶çÁö ¾ÊÀº °æ¿ìµµ Àִµ¥ À̶§´Â ÁøÂûÀ» ÇØµµ °¨±â³ª ±Þ¼ºÀ§Ã¢ÀÚ¿°À¸·Î ÀÚÄ© ¿ÀÁøµÇ±â ½±´Ù. ¶Ç AÇü°£¿°Àº ¿ÀÌ 38~39¡É±îÁö ¿À¸£°í Áõ¼¼°¡ °©Àڱ⠳ªÅ¸³ª´Â °ÍÀÌ Æ¯Â¡ÀÌ¸ç ±Þ¼ººñAºñBÇü°£¿°Àº Áõ¼¼°¡ ºñ±³Àû °¡º¿î °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ±Þ¼ºBÇü°£¿°ÀÇ Áõ¼¼´Â AÇü°£¿°°ú ±Þ¼ººñAºñBÇü°£¿°ÀÇ Áß°£ Á¤µµÀÎ °ÍÀÌ º¸ÅëÀÌ´Ù. |
||
| ¿µ¹® | liver cirrhosis | ÇÑ±Û | °£°æÈ(Áõ) |
|---|---|---|---|
| ¼³¸í | Á¤»óÀûÀÎ °£¼¼Æ÷ÀÇ ¸¹Àº ºÎºÐÀÌ ¼Ò½ÇÀÌ µÇ°í ´ë½Å¿¡ ¼¶À¯Á¶Á÷À¸·Î ´ëÄ¡µÇ¾î ÀÖ´Â °£ÀÇ º´Àû »óŸ¦ ¸»ÇÑ´Ù. °£¼¼Æ÷ÀÇ ¸¹Àº ¼Õ»óÀ» °¡Á®¿À´Â ¸ðµç º´¿¡¼ °£°æÈ°¡ ÀϾÙ. ±×·¯³ª ´ëºÎºÐÀÇ °£°æÈÀÇ ¿øÀÎÀº °£¿°°ú ¼ú¿¡ ÀÇÇÑ °£¼Õ»óÀÌ´Ù. °£°æÈÀÇ Áõ»óÀº ¿øÀο¡ µû¶ó¼ ´ÙÀ½°ú °°Àº µÎ °¡Áö·Î ³ª´ ¼ö°¡ ÀÖ´Ù. ù°´Â ¿ì¼± °£ÀÇ ±â´ÉÀÇ Àå¾Ö¿¡ ÀÇÇÑ Áõ»óÀÌ´Ù. °£¼¼Æ÷ÀÇ »ó´ç¼ö°¡ ¼¶À¯Á¶Á÷À¸·Î ´ëüµÇ¾î ÀÖ´Â »óÅÂÀ̹ǷΠ°£ÀÇ ±â´ÉÀÇ Àå¾Ö°¡ »ý±â´Â °ÍÀº ´ç¿¬ÇÏ´Ù. Ȳ´Þ µîÀÌ ´ëÇ¥Àû ¿¹¶ó ÇϰڴÙ. µÎ¹øÂ°´Â ¹®¸Æ¾ÐÇ×Áø(portal hypertension)¿¡ ÀÇÇÑ Áõ»óµéÀÌ´Ù. À§, ÀÛÀºÃ¢ÀÚ³ª ūâÀÚ¿¡¼ ¿µ¾çºÐÀ» Èí¼öÇϱâÀ§ÇÑ ¸ð¼¼Ç÷°üÁ¶Á÷Àº ¸ðµÎ °£À¸·Î ¿¬°áÀÌ µÈ´Ù. Áï ¼Òȱ⿡¼ Èí¼öÇÑ ¿µ¾çºÐÀÌ °¡µæÇÑ ÇÇ´Â ¸ðµÎ °£À¸·Î ¿¬°áµÇ´Âµ¥ À̰ÍÀ» ¹®¸Æ°è(portal system)¶ó°í ÇÑ´Ù. °£°æÈÀÇ °æ¿ì¿¡´Â ¼¶À¯¼ºÁ¶Á÷ÀÌ °£Á¶Á÷À» °ÅÀÇ ´ëÄ¡ÇÔÀ¸·Î Á¤»ó °£¼¼Æ÷³»¿¡¼± ³ÐÀº °ø°£À» Â÷ÁöÇÏ´ø °£³»ÀÇ Ç÷°üµéÀÌ ¼¶À¯Á¶Á÷¿¡ ´¸®°Ô µÈ´Ù. ±×·¯¸é À̰Ͱú ¿¬°áµÈ ¹®¸Æ°èÀÇ ¾Ð·Âµµ ³ô¾ÆÁö°Ô µÈ´Ù. ¹®¸Æ¾ÐÀÇ »ó½ÂÀÌ ÀÖ´Â °æ¿ì¿¡´Â ¹®¸Æ°è¿¡ ¿¬°áÀÌ µÇ¾î ÀÖ´Â ¸ðµç ºÎºÐÀÇ Á¤¸ÆÀÇ ¾Ð·ÂÀÌ ³ô¾ÆÁö°í Á¤¸ÆÀÇ ¼øÈ¯ÀÌ Á¤ÁöµÈ »óŰ¡ µÈ´Ù. Áö¶óÀÇ °æ¿ìµµ ¹®¸Æ°è¿¡ ¿¬°áµÈ Àå±âÀ̹ǷΠ¹®¸Æ¾Ð »ó½Â½Ã¿¡´Â Á¤¸ÆÀÇ ¼øÈ¯ÀÌ ¾ø¾îÁö°í, µ¿¸ÆÀ¸·Î À¯ÀÔÀÌ µÇ´Â Ç÷¾×Àº °è¼Ó µé¾î¿À¹Ç·Î Áö¶óÀÌ Ä¿Áö°Ô µÈ´Ù. ¶Ç ¼ÒȱâÀÇ ¸ð¼¼Ç÷°ü³»¿¡¼ÀÇ ¾Ð·Âµµ ³ô¾ÆÁö°Ô µÇ°í ±×·¯¸é ±× ¾Ð·Â¿¡ ÀÇÇØ¼ ¸¹Àº ¾çÀÇ ¼öºÐÀÌ ¸ð¼¼Ç÷°ü¹ÛÀ¸·Î ºüÁ®³ª¿À°Ô µÈ´Ù. ÀÌ ¼öºÐÀÌ ¸ð¿© º¹¼ö°¡ µÈ´Ù. |
||
| ¿µ¹® | liver function tests | ÇÑ±Û | °£±â´É°Ë»ç |
|---|---|---|---|
| ¼³¸í | Ç÷¾×°Ë»çÁß °¡Àå ¸¹ÀÌ ¾²ÀÌ´Â °Ë»ç¹ýÀ¸·Î ´ÙÀ½ 7°¡Áö¸¦ °Ë»çÇÏ°Ô µÈ´Ù. Ç÷ûÄÝ·¹½ºÅ×·Ñ, ÃѴܹéÁú, ¾ËºÎ¹Î, ºô¸®·çºó, GOT/GPT È¿¼Ò, ¾ËÄ®¸®ÀλêºÐÇØÈ¿¼Ò(alkaline phophatase) µîÀ» °Ë»çÇÏ°Ô µÇ´Â µ¥ °¢ °Ë»çÄ¡¿¡´Â ¸ðµÎ Àǹ̰¡ ÀÖÀ¸¸ç, ÀÌ °Ë»ç Çϳª·Î °£±â´ÉÀÇ Àü¹ÝÀûÀÎ »óÅ¿¡ ´ëÇØ¼ ¾Ë¾Æº¼ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | liver biopsy | ÇÑ±Û | °£»ý°Ë |
|---|---|---|---|
| ¼³¸í | »ç¶÷ÀÌ »ì¾ÆÀÖ´Â »óÅ¿¡¼ º´Å͸¦ Àß¶ó³»¾î Á÷Á¢ Çö¹Ì°æ µîÀ¸·Î º¸¾Æ Áø´ÜÀ» ³»¸®´Â Áø´Ü¹ýÀÌ´Ù. °£»ý°ËÀº ÁÖ·Î °£¿°À̳ª °£¾ÏÀÇ Áø´ÜÀ̳ª, Èñ±ÍÇÑ À¯Àüº´, ¼±Ãµº´ µîÀÇ È®Áø¿¡ ÀÌ¿ëµÈ´Ù. °£¿°¿¡¼´Â ÇöÀçÀÇ °£¿°ÀÌ ÁøÇ༺ÀÎÁö ȤÀº ºñÁøÇ༺ÀÎÁö ¶Ç´Â ÀÌ¹Ì °£°æÈ»óÅ·Π³Ñ¾î°¬´ÂÁö µîÀÇ ¿©ºÎ¸¦ ¾Ë¾Æº¸°Ô µÈ´Ù. |
||
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
|---|---|
| AFP | Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
| AML | Acute Myelogenous Leukemia Morphologic Classification(FABºÐ·ù) &n... |
| AD | accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade... |
| AH | abdominal hysterectomy; absorptive hypercalciuria; accidental hypothermia; acetohexamide; acid hydro... |
| ATSDR | Agency for Toxic Substances and Disease Registry |
|---|---|
| AFLP | Acute fatty liver of pregnancy |
| ALF | Acute liver failure |
| AAH | Acute alcoholic hepatitis |
| AH | Acute hepatitis |
acute angle
acute arthritis
acute monocytic leukemia
| hepatitis, toxic | Acute hepatitis caused by true hepatotoxins such as amanita phaloides toxin, carbon tetrachloride, yellow phosphorus, and a variety of drugs. (12 Dec 1998) |
|---|---|
| acute parenchymatous hepatitis | A lesion in which there is extensive and rapid death of parenchymal cells of the liver, sometimes with fatty degeneration of the size of the organ; the necrosis may result from fulminant viral infection or chemical poisoning; associated with jaundice. Synonym: acute parenchymatous hepatitis, Rokitansky's disease. (05 Mar 2000) |
| acute yellow atrophy of the liver | A lesion in which there is extensive and rapid death of parenchymal cells of the liver, sometimes with fatty degeneration of the size of the organ; the necrosis may result from fulminant viral infection or chemical poisoning; associated with jaundice. Synonym: acute parenchymatous hepatitis, Rokitansky's disease. (05 Mar 2000) |
| liver failure, acute | A form of liver failure with rapid onset. It is often induced by the toxic effect of drugs and various toxic substances in experimental studies in animals and in clinical states in humans. If coma ensues, the constellation of neurological symptoms is referred to as hepatic encephalopathy. (12 Dec 1998) |
| alcoholic liver disease | <gastroenterology> Alcoholic cirrhosis is a condition of irreversible liver disease due to the chronic inflammatory and toxic effects of ethanol on the liver. In cirrhosis, the liver cells are replaced by fibrous scar tissue. Fibrosis leads to the development of portal hypertension. The development of cirrhosis is directly related to the duration and quantity of alcohol consumption. The manifestations of cirrhosis are related to the liver's inability to not adequately remove waste products from the bloodstream and the effects of portal hypertension. (15 Nov 1997) |
| veno-occlusive disease of the liver | Obliterating endophlebitis of small hepatic vein radicles, described in Jamaican children, associated with ingestion of toxic plant substances in bush tea; causes ascites, which may progress to cirrhosis. (05 Mar 2000) |
| chronic active liver disease | Any of several types of hepatitis persisting for more than six months, often progressing to cirrhosis. Synonym: chronic active liver disease. (05 Mar 2000) |
| polycystic liver disease | Gradual cystic dilation of intralobular bile ducts (Meyenburg's complexes) that fail to involute in embryologic development of the liver; frequently associated with bilateral congenital polycystic kidneys and occasionally with cystic involvement of the pancreas, lungs, and other organs. Synonym: polycystic liver disease. (05 Mar 2000) |
| acute disease | Disease having a short and relatively severe course. (12 Dec 1998) |
| megacolon, toxic | Acute dilatation of the colon associated with amebic or ulcerative colitis. The dilatation may precede perforation of the colon. (12 Dec 1998) |
| goiter, diffuse toxic | Graves' disease, the most common cause of hyperthroidism, too much thyroid hormone. (12 Dec 1998) |
| goiter, toxic multinodular | Condition in which the thyroid gland contains multiple lumps (nodules) that are overactive and produce excess thyroid hormones. This condition is also known as Parry's disease or Plummer's disease. (12 Dec 1998) |
| plants, toxic | Plants or plant parts which are harmful to man or other animals. (12 Dec 1998) |
| shock, toxic | See Syndrome, toxic shock. (12 Dec 1998) |
| syndrome, toxic shock | A grave condition occurring predominantly in menstruating women using tampons, toxic shock is characterised by a highly toxic state (with sudden high fever, vomiting, diarrhoea, muscle aching) followed by low blood pressure (hypotension) which can lead to shock (and death). There may be a rash resembling sunburn with peeling of skin. The channing laboratory in boston under dr. Edw. Kass discovered that toxic shock was due to a toxin produced by staph (staphylococcus) aureus bacteria growing under conditions with little or no oxygen. The syndrome occurs rarely in women not using tampons and in men. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|